STOCK TITAN

Revolution Medicines, Inc. Warrant (RVMDW) Net Income by Year

RVMDW

Revolution Medicines, Inc. Warrant reported a net loss of $1.1B in fiscal year 2025. This represents a decrease of 88.5% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Revolution Medicines, Inc. Warrant has filed alongside them.

FY2025 annual
Net Income -$1.1B
YoY -88.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RVMDW Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Net Income-$1.1B-88.5%-$600.0M-37.6%-$436.0M-75.1%-$249.0M-33.2%-$187.0M-72.9%-$108.2M-126.9%-$47.7M-14.1%-$41.8M

RVMDW Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$644.4M-160.1%-$453.8M-112.6%N/A-$305.2M-95.3%-$247.8M-86.0%-$213.4M-84.0%N/A-$156.3M-44.1%-$133.2M-35.5%-$116.0M-70.3%N/A-$108.4M-47.9%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Revolution Medicines, Inc. Warrant financials

Frequently Asked Questions

What was Revolution Medicines, Inc. Warrant's net income in fiscal year 2025?

Revolution Medicines, Inc. Warrant reported a net loss of $1.1B in fiscal year 2025.

How fast is Revolution Medicines, Inc. Warrant's net income growing?

Revolution Medicines, Inc. Warrant (RVMDW) net income fell by 88.5% year over year, from -$600.0M to -$1.1B in fiscal year 2025.

How has Revolution Medicines, Inc. Warrant's net income changed over the years?

Across the 8 fiscal years this page covers, Revolution Medicines, Inc. Warrant (RVMDW) net income went from -$41.8M in fiscal year 2018 to -$1.1B in fiscal year 2025.

Revolution Medicines, Inc. Warrant (RVMDW) reported -$644.4M in net income in Q2 2026. This represents a decrease of 160.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Revolution Medicines, Inc. Warrant (RVMDW) reported on that line in every period on record.